Article
Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL.
Drug metabolism and personalized therapy - 1 Sept 2015
Zaruma-Torres Fausto, Lares-Asseff Ismael, Reyes-Espinoza Aarón, Loera-Castañeda Verónica, Chairez-Hernández Isaías, Sosa-Macías Martha, Galaviz-Hernández Carlos, Almanza-Reyes Horacio
Abstract excerpt
BACKGROUND: Acute lymphoblastic leukemia (ALL) is one of the most frequent oncological disorders in pediatric populations. To date, the drug of choice for the treatment of ALL is methotrexate, a drug associated with a high risk of adverse reactions (ADRs). The xanthine oxidase (XO) polymorphisms, 1936A>G and 2107A>G, as well as the polymorphic variants derived from ATP-binding cassette transporter gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
